GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application.

Dominika Myśliwczyk; Małgorzata Myśliwiec; Alina Minarowska; Eliza Wasilewska

doi:10.3390/ijms27188191

SCHEDA SCIENTIFICA2026Altra ricerca

GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application.

Dominika Myśliwczyk, Małgorzata Myśliwiec, Alina Minarowska, Eliza Wasilewska

International journal of molecular sciences · 2026

Psicologia clinica Psicoterapia Neuroscienze Psicologia cognitiva Psicologia dello sviluppo

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansGlucagon-Like Peptide-1 Receptor AgonistsSemaglutidePediatric ObesityChildGlucagon-Like Peptide-1 ReceptorTirzepatideReceptors, Gastrointestinal HormoneGastric Inhibitory PolypeptideNeurosecretory SystemsAnimalsGlucagon-Like PeptidesIncretinsLiraglutideGIP/GLP-1 receptor agonistsGLP-1 receptor agonistsgut–brain axisliraglutideneuroendocrine regulationpediatric obesitysemaglutidetirzepatide

Come citare questo studio

Dominika Myśliwczyk, Małgorzata Myśliwiec, Alina Minarowska, Eliza Wasilewska. (2026). GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application.. International journal of molecular sciences. DOI: 10.3390/ijms27188191

Consulta la pubblicazione originale ↗